Christopher M. Coleman
University of Nottingham(GB)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Long-Term Effects of COVID-19, Animal Virus Infections Studies, Viral gastroenteritis research and epidemiology
Most-Cited Works
- → Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection(2014)697 cited
- → Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection(2019)383 cited
- → Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice(2014)305 cited
- → Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion(2016)274 cited
- → Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo(2020)233 cited
- → HIV interactions with monocytes and dendritic cells: viral latency and reservoirs(2009)233 cited
- → Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection(2015)220 cited
- → Coronaviruses: Important Emerging Human Pathogens(2014)212 cited
- → SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+T-lymphocytes cannot be upregulated by interferons(2012)192 cited
- → Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference(2015)158 cited